FR2368272A1 - Compositions therapeutiques solides pour combattre l'agregation plaquettaire - Google Patents

Compositions therapeutiques solides pour combattre l'agregation plaquettaire

Info

Publication number
FR2368272A1
FR2368272A1 FR7631562A FR7631562A FR2368272A1 FR 2368272 A1 FR2368272 A1 FR 2368272A1 FR 7631562 A FR7631562 A FR 7631562A FR 7631562 A FR7631562 A FR 7631562A FR 2368272 A1 FR2368272 A1 FR 2368272A1
Authority
FR
France
Prior art keywords
dipyridamole
sepd
compsns
platelet aggregation
inert material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7631562A
Other languages
English (en)
Other versions
FR2368272B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Theramex SAM
Original Assignee
Laboratoire Theramex SAM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Theramex SAM filed Critical Laboratoire Theramex SAM
Priority to FR7631562A priority Critical patent/FR2368272A1/fr
Publication of FR2368272A1 publication Critical patent/FR2368272A1/fr
Application granted granted Critical
Publication of FR2368272B1 publication Critical patent/FR2368272B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof

Abstract

L'invention concerne une nouvelle composition thérapeutique, caractérisée en ce qu'elle comprend une association d'acide acétylsalicylique et/ou de ses derivés avec le dipyridamole, chaque principe actif étant associé à un véhicule et/ou un excipient l'isolant de l'autre principe actif. Application en tant que médicaments anti-agrégants plaquettaires
FR7631562A 1976-10-20 1976-10-20 Compositions therapeutiques solides pour combattre l'agregation plaquettaire Granted FR2368272A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7631562A FR2368272A1 (fr) 1976-10-20 1976-10-20 Compositions therapeutiques solides pour combattre l'agregation plaquettaire

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7631562A FR2368272A1 (fr) 1976-10-20 1976-10-20 Compositions therapeutiques solides pour combattre l'agregation plaquettaire

Publications (2)

Publication Number Publication Date
FR2368272A1 true FR2368272A1 (fr) 1978-05-19
FR2368272B1 FR2368272B1 (fr) 1980-10-03

Family

ID=9178999

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7631562A Granted FR2368272A1 (fr) 1976-10-20 1976-10-20 Compositions therapeutiques solides pour combattre l'agregation plaquettaire

Country Status (1)

Country Link
FR (1) FR2368272A1 (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2452923A2 (fr) * 1979-04-02 1980-10-31 Panoz Donald Nouvelle forme galenique d'administration de medicaments par voie orale, a liberation programmee
EP0169465A2 (fr) * 1984-07-21 1986-01-29 Hoechst Aktiengesellschaft Mélange de pyrimido-pyrimidines et d'acide O-acétyl-salicyclique, et/ou de leurs sels pharmacologiquement acceptables et son application
US4609542A (en) * 1978-12-22 1986-09-02 Elan Corporation, P.L.C. New pharmaceutical forms for administration of medicaments by oral route, with programmed release
EP0257344A1 (fr) * 1986-08-13 1988-03-02 Dr. Karl Thomae GmbH Médicaments contenant du dipyridamol ou mopidamol et de l'acide O-acétylsalicylique ou ses sels compatibles physiologiquement, procédé pour leur préparation et leur application pour combattre la formation de thrombus
EP0449426A1 (fr) * 1990-02-26 1991-10-02 Byrne Rynne Holdings Limited Composition pharmaceutique
EP0676204A1 (fr) * 1992-07-30 1995-10-11 Cal International Limited Combinaisons d'un nitrate organique et un salicylate

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4609542A (en) * 1978-12-22 1986-09-02 Elan Corporation, P.L.C. New pharmaceutical forms for administration of medicaments by oral route, with programmed release
US4726951A (en) * 1978-12-22 1988-02-23 Elan Corporation P.L.C. New pharmaceutical forms for administration of medicaments by oral route, with programmed release
FR2452923A2 (fr) * 1979-04-02 1980-10-31 Panoz Donald Nouvelle forme galenique d'administration de medicaments par voie orale, a liberation programmee
EP0169465A2 (fr) * 1984-07-21 1986-01-29 Hoechst Aktiengesellschaft Mélange de pyrimido-pyrimidines et d'acide O-acétyl-salicyclique, et/ou de leurs sels pharmacologiquement acceptables et son application
EP0169465A3 (en) * 1984-07-21 1986-05-28 Hoechst Aktiengesellschaft Mixture of pyrimido-pyrimidines and o-acetyl-salicylic acid, or their pharmacologically acceptable salts, and its use
EP0257344A1 (fr) * 1986-08-13 1988-03-02 Dr. Karl Thomae GmbH Médicaments contenant du dipyridamol ou mopidamol et de l'acide O-acétylsalicylique ou ses sels compatibles physiologiquement, procédé pour leur préparation et leur application pour combattre la formation de thrombus
AU603146B2 (en) * 1986-08-13 1990-11-08 Dr. Karl Thomae Gmbh Pharmaceutical compositions containing dipyridamole or mopidamol and o-acetylsalicylic acid or the physiologically acceptable salts thereof
US6015577A (en) * 1986-08-13 2000-01-18 Dr. Karl Thomae GmbH Pharmaceutical compositions containing dipyridamole or mopidamol and acetylsalicylic acid or the physiologically acceptable salts thereof, processes for preparing them and their use in treating clot formation
EP0449426A1 (fr) * 1990-02-26 1991-10-02 Byrne Rynne Holdings Limited Composition pharmaceutique
US5156849A (en) * 1990-02-26 1992-10-20 Byrne Rynne Holdings Limited Pharmaceutical composition
EP0676204A1 (fr) * 1992-07-30 1995-10-11 Cal International Limited Combinaisons d'un nitrate organique et un salicylate

Also Published As

Publication number Publication date
FR2368272B1 (fr) 1980-10-03

Similar Documents

Publication Publication Date Title
GB2048960B (en) Coating articles with layers of hard materials
IE41993L (en) Diaphragm for electroacoustic converter
NO165838C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte trans-1,2-diamino-cykloheksylamidforbindelser.
YU42977A (en) Process for the preparation of bonded and co-extruded two -or multi-layer articles manufacturinred from thermoplastic materials which are impermeable for gases, vapours and odors
NO864243D0 (no) Flerlags granuler og fremgangsmaate for deres fremstilling.
NO892420L (no) Fremgangsmaate for fremstilling av laminerte materialer.
NO161802C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive furo-(3,4-c)-pyridinderivater.
NO893616L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tricykliske forbindelser.
NO163184C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive 4h-3, 1-benzoksazin-4-on-derivater.
NO165922C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive estere av hexahydro-8-hydroxy-2,6-methano-2h-kinolizin-3-(4h)-on og beslektede forbindelser.
FR2368272A1 (fr) Compositions therapeutiques solides pour combattre l'agregation plaquettaire
DE3161799D1 (en) Photosensible multilayer material and process for the production of subbing layers therefor
NO153930C (no) Framgangsmaate for framstilling av et legert, nikkelfritt staal med kryogene egenskaper.
GB2075368B (en) Composite material with two or plurality of layers
DE3468325D1 (en) Cytotoxic pharmaceutical association, especially suited for the treatment of cancers
DE3369641D1 (en) Use of a benzoisothiazoline derivative for the manufacture of a medicament against thrombosis and platelet aggregation
DE2960612D1 (en) Blood platelet aggregation inhibitory pyridine derivatives, pharmaceutical compositions thereof, and processes for their manufacture
AU2821384A (en) Polymeric-coated fabric layer product utilizing the layer andmethod of making the same
PH16253A (en) Dibenzazepine derivatives,pharmaceutical composition containing them and use of the compound
NO165595C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4,5,6,7-tetrahydrotiazolo<5,4-c>pyridinderivater.
JPS579780A (en) Carbostyril derivative
NO162617C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tricykliske imidazolderivater.
CA974245A (en) Stereoisomers of 1-(1'-(o-chlorobenzyl)-2'-pyrryl)-2-disec.butylamino-ethanol
ZA807912B (en) Benzenesulfonylureas, process for their manufacture, pharmaceutical preparations on the basis of these compounds and their use
NO153849C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridinderivater.

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse